Generic and Biosimilar Cancer Medicines
key details
| Value | £59,145,973 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | Scotland |
| Deadline | 17 Oct 2022 |
| Procedure | open |
| OCID | ocds-h6vhtk-0368ee |
Awards (29)
This procurement was awarded to 29 suppliers. Values shown are per-award; the notice total is £59,145,973.
description
This Framework Agreement is for the supply of generic and biosimilar cancer medicines to NHS Scotland.
The Goods were separated into forty-one (41) categories, each of which is identified as a “Lot”.
Full details of each awarded Lot is contained in section II.2 of this Notice.
documents
- Generic and Biosimilar Cancer Medicines , awardNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 16 Sept 2022 | Contract notice (F02) | Earlier regulations | 025989-2022 |
| 21 Apr 2023 | Contract award notice (F03) | Earlier regulations | 011419-2023 |
more from The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
- NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines · £22,471,323 · 6 Jan 2026
- Contrast Media Agents · £44,036,295 · 27 Jun 2024
- NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines · £35,467,873 · 7 Mar 2024
- NP811-17 Lift Maintenance Services · £5,750,000 · 19 Jul 2023
- NP36722 Fertility Products · £6,490,616 · 18 Jan 2023
- NP41422 Contraceptive Medicines · £7,369,432 · 8 Jul 2022
- NP39722f Lenalidomide · £4,300,000 · 7 Jun 2022
- Generic Medicines Transition Tender · £1,798,519 · 20 May 2022
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Public Contracts Scotland. Contact details for named individuals are not reproduced on this site.